← Back to Search

Tylenol and NSAIDS (Ibuprofen, diclofenac) for Shoulder Pain

N/A
Waitlist Available
Led By Umasuthan Srikumaran, M.D.
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Opioid-naive adults age 18-90 years old planning to undergo surgical treatment for shoulder pathology with the PI at Johns Hopkins Shoulder Service (Columbia, Odenton clinic sites; Howard County General Hospital/Johns Hopkins Hospital operative sites) will be included.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2-4 months postop
Awards & highlights

Study Summary

This trial will study how often opioids and non-opioid painkillers are used following shoulder surgery, and create guidelines for standard post-operative pain management based on the evidence.

Eligible Conditions
  • Shoulder Pain

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2-4 months postop
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2-4 months postop for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Morphine milligram equivalents (MMEs) consumed
Office Contacts
Opioid Prescription Refills
Secondary outcome measures
American Shoulder and Elbow Surgeons (ASES) score

Trial Design

3Treatment groups
Experimental Treatment
Group I: Group 3Experimental Treatment1 Intervention
Participants will not be aware of the relation to the group they are randomized into in comparison to the other study groups; for example, if they were assigned a higher or lower frequency of ice usage (with Intervention 1 being frequency of ice usage), etc.
Group II: Group 2Experimental Treatment1 Intervention
Participants will not be aware of the relation to the group they are randomized into in comparison to the other study groups; for example, if they were assigned a higher or lower frequency of ice usage (with Intervention 1 being frequency of ice usage), etc.
Group III: Group 1Experimental Treatment1 Intervention
Participants will not be aware of the relation to the group they are randomized into in comparison to the other study groups; for example, if they were assigned a higher or lower frequency of ice usage (with Intervention 1 being frequency of ice usage), etc.

Find a Location

Who is running the clinical trial?

American Shoulder and Elbow SurgeonsOTHER
2 Previous Clinical Trials
150 Total Patients Enrolled
Johns Hopkins UniversityLead Sponsor
2,260 Previous Clinical Trials
14,820,706 Total Patients Enrolled
2 Trials studying Shoulder Pain
108 Patients Enrolled for Shoulder Pain
Umasuthan Srikumaran, M.D.Principal InvestigatorJohns Hopkins Orthopedics

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants aged 65 and above allowed to join this research?

"Individuals aged 18-90 are eligible to participate in this clinical investigation."

Answered by AI

Is enrollment in this experiment open to volunteers at present?

"As per the data hosted on clinicaltrials.gov, this research is actively recruiting participants. This experiment was first published on December 1st 2020 and has been most recently revised as of October 12th 2022."

Answered by AI

What are the eligibility criteria for participating in this trial?

"This medical experiment is looking for 540 patients aged 18-90 who suffer from shoulder discomfort. The primary requirement to be included in the trial is that prospective participants must not have been exposed to opioids, and should plan on having their procedure done at either of the two sites managed by Johns Hopkins Shoulder Service (Columbia or Odenton clinic; Howard County General Hospital/Johns Hopkins Hospital operative)."

Answered by AI

How many participants are allowed to join this clinical test?

"Affirmative. Clinicaltrials.gov indicates that this clinical trial, published on December 1st 2020, is still recruiting participants. The study requires 540 volunteers from a single location to be enrolled in the experiment."

Answered by AI
~17 spots leftby Apr 2025